BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25732979)

  • 21. Asymmetric dimethyl L-arginine (ADMA) is a critical regulator of myocardial reperfusion injury.
    Stühlinger MC; Conci E; Haubner BJ; Stocker EM; Schwaighofer J; Cooke JP; Tsao PS; Pachinger O; Metzler B
    Cardiovasc Res; 2007 Jul; 75(2):417-25. PubMed ID: 17559823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The DDAH/ADMA pathway is a critical regulator of NO signalling in vascular homeostasis.
    Fiedler L
    Cell Adh Migr; 2008; 2(3):149-50. PubMed ID: 19270535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human recombinant erythropoietin augments serum asymmetric dimethylarginine concentrations but does not compromise nitric oxide generation in mice.
    Desai A; Zhao Y; Warren JS
    Nephrol Dial Transplant; 2008 May; 23(5):1513-20. PubMed ID: 18204093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A new key player in VEGF-dependent angiogenesis in human hepatocellular carcinoma: dimethylarginine dimethylaminohydrolase 1.
    Buijs N; Oosterink JE; Jessup M; Schierbeek H; Stolz DB; Houdijk AP; Geller DA; van Leeuwen PA
    Angiogenesis; 2017 Nov; 20(4):557-565. PubMed ID: 28741166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severely decreased activity of placental dimethylarginine dimethylaminohydrolase in pre-eclampsia.
    Anderssohn M; Maass LM; Diemert A; Lüneburg N; Atzler D; Hecher K; Böger RH
    Eur J Obstet Gynecol Reprod Biol; 2012 Apr; 161(2):152-6. PubMed ID: 22285683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probucol decreases asymmetrical dimethylarginine level by alternation of protein arginine methyltransferase I and dimethylarginine dimethylaminohydrolase activity.
    Jiang JL; Zhang XH; Li NS; Rang WQ; Feng-Ye ; Hu CP; Li YJ; Deng HW
    Cardiovasc Drugs Ther; 2006 Aug; 20(4):281-94. PubMed ID: 16897158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dimethylarginine dimethylaminohydrolase-2 overexpression improves impaired nitric oxide synthesis of endothelial cells induced by glycated protein.
    Lu CW; Xiong Y; He P
    Nitric Oxide; 2007 Feb; 16(1):94-103. PubMed ID: 16979918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dimethylarginine dimethylaminohydrolase promotes endothelial repair after vascular injury.
    Konishi H; Sydow K; Cooke JP
    J Am Coll Cardiol; 2007 Mar; 49(10):1099-105. PubMed ID: 17349891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effect of neferine on endothelial cell nitric oxide production induced by lysophosphatidylcholine: the role of the DDAH-ADMA pathway.
    Peng ZY; Zhang SD; Liu S; He BM
    Can J Physiol Pharmacol; 2011 Apr; 89(4):289-94. PubMed ID: 21526974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dimethylarginine dimethylaminohydrolase 1 modulates endothelial cell growth through nitric oxide and Akt.
    Zhang P; Hu X; Xu X; Chen Y; Bache RJ
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):890-7. PubMed ID: 21212404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The ADMA/DDAH pathway is a critical regulator of endothelial cell motility.
    Wojciak-Stothard B; Torondel B; Tsang LY; Fleming I; Fisslthaler B; Leiper JM; Vallance P
    J Cell Sci; 2007 Mar; 120(Pt 6):929-42. PubMed ID: 17327280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The ADMA/DDAH/NO pathway in human vein endothelial cells exposed to arsenite.
    Osorio-Yáñez C; Chin-Chan M; Sánchez-Peña LC; Atzatzi-Aguilar OG; Olivares-Reyes JA; Segovia J; Del Razo LM
    Toxicol In Vitro; 2017 Aug; 42():281-286. PubMed ID: 28502835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA).
    Reddy KRK; Dasari C; Duscharla D; Supriya B; Ram NS; Surekha MV; Kumar JM; Ummanni R
    Angiogenesis; 2018 Feb; 21(1):79-94. PubMed ID: 29150732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase.
    Ito A; Tsao PS; Adimoolam S; Kimoto M; Ogawa T; Cooke JP
    Circulation; 1999 Jun; 99(24):3092-5. PubMed ID: 10377069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preservation of vascular DDAH activity contributes to the protection of captopril against endothelial dysfunction in hyperlipidemic rabbits.
    Lin Y; Feng M; Lu CW; Lei YP; He ZM; Xiong Y
    Eur J Pharmacol; 2017 Mar; 798():43-48. PubMed ID: 28163022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of DDAH/ADMA/NOS regulation pathway on cavernae corporum cavernosorum rat penis of different age.
    Wang JH; Chen D; Zhang KQ; Zhang H; Fu Q
    Andrologia; 2016 Apr; 48(3):262-7. PubMed ID: 26011316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variance of DDAH/PRMT/ADMA pathway in atrial fibrillation dogs.
    Liu H; Qu X; Liang Z; Chen W; Xia W; Song Y
    Biochem Biophys Res Commun; 2008 Dec; 377(3):884-8. PubMed ID: 18951871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of telmisartan on nitric oxide--asymmetrical dimethylarginine system: role of angiotensin II type 1 receptor gamma and peroxisome proliferator activated receptor gamma signaling during endothelial aging.
    Scalera F; Martens-Lobenhoffer J; Bukowska A; Lendeckel U; Täger M; Bode-Böger SM
    Hypertension; 2008 Mar; 51(3):696-703. PubMed ID: 18250362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of ezetimibe on ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
    Trocha M; Merwid-Ląd A; Sozański T; Ewa Chlebda-Sieragowska E; Szuba A; Dzięgiel P; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Gomułkiewicz A; Cwynar-Zając Ł; Brykner R; Szeląg A
    Pharmacol Rep; 2013; 65(1):122-33. PubMed ID: 23563030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effect of resveratrol derivative BTM-0512 on high glucose-induced cell senescence involves dimethylaminohydrolase/asymmetric dimethylarginine pathway.
    Yuan Q; Peng J; Liu SY; Wang CJ; Xiang DX; Xiong XM; Hu CP; Li YJ
    Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):630-5. PubMed ID: 20132235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.